1. Home
  2. XAIR vs SSKN Comparison

XAIR vs SSKN Comparison

Compare XAIR & SSKN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Beyond Air Inc.

XAIR

Beyond Air Inc.

HOLD

Current Price

$0.94

Market Cap

10.5M

Sector

Health Care

ML Signal

HOLD

Logo Strata Skin Sciences Inc.

SSKN

Strata Skin Sciences Inc.

HOLD

Current Price

$1.22

Market Cap

8.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XAIR
SSKN
Founded
2011
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.5M
8.9M
IPO Year
N/A
2005

Fundamental Metrics

Financial Performance
Metric
XAIR
SSKN
Price
$0.94
$1.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
1
Target Price
$11.00
$6.00
AVG Volume (30 Days)
118.3K
70.1K
Earning Date
11-10-2025
11-13-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$5,802,000.00
$30,980,000.00
Revenue This Year
$128.45
N/A
Revenue Next Year
$153.25
$7.74
P/E Ratio
N/A
N/A
Revenue Growth
147.74
N/A
52 Week Low
$0.90
$1.23
52 Week High
$11.20
$3.86

Technical Indicators

Market Signals
Indicator
XAIR
SSKN
Relative Strength Index (RSI) 28.95 36.39
Support Level $0.91 $1.29
Resistance Level $1.31 $1.37
Average True Range (ATR) 0.09 0.08
MACD 0.01 -0.01
Stochastic Oscillator 11.36 7.91

Price Performance

Historical Comparison
XAIR
SSKN

About XAIR Beyond Air Inc.

Beyond Air Inc is a commercial-stage medical device and biopharmaceutical company that develops a Nitric Oxide (NO) Generator and Delivery System that uses NO generated from ambient air and delivers precise amounts of NO to the lungs for the potential treatment of respiratory and other diseases. The firm is applying its therapeutic expertise to develop treatments for pulmonary hypertension, in addition to treatments for lower respiratory tract infections.

About SSKN Strata Skin Sciences Inc.

Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: